Genome wide association (GWA) is emerging as a powerful new tool for identifying genetic variants related to common complex diseases, including diabetes and cancer. This article reviews recent successes that demonstrate the potential of GWA studies to identify genetic biomarkers of disease and reveal novel therapeutic targets and strategies.
- Stephen F. Kingsmore
- Ingrid E. Lindquist
- William D. Beavis